Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) Sees Large Increase in Short Interest

Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) saw a significant increase in short interest in September. As of September 30th, there was short interest totalling 122,300 shares, an increase of 86.7% from the September 15th total of 65,500 shares. Approximately 0.7% of the company’s stock are sold short. Based on an average daily trading volume, of 115,500 shares, the short-interest ratio is currently 1.1 days.

Inspira Technologies Oxy B.H.N. Stock Up 0.8 %

NASDAQ:IINN opened at $1.37 on Monday. Inspira Technologies Oxy B.H.N. has a 1 year low of $0.76 and a 1 year high of $2.49. The company has a quick ratio of 2.13, a current ratio of 2.23 and a debt-to-equity ratio of 0.09. The stock has a 50-day simple moving average of $1.17 and a 200-day simple moving average of $1.54.

Hedge Funds Weigh In On Inspira Technologies Oxy B.H.N.

An institutional investor recently bought a new position in Inspira Technologies Oxy B.H.N. stock. Renaissance Technologies LLC purchased a new stake in Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 24,497 shares of the company’s stock, valued at approximately $34,000. Renaissance Technologies LLC owned about 0.19% of Inspira Technologies Oxy B.H.N. at the end of the most recent reporting period. Institutional investors own 12.72% of the company’s stock.

Inspira Technologies Oxy B.H.N. Company Profile

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.